Related Experiment Videos
HETEs/EETs in renal glomerular and epithelial cell functions
Rama Natarajan1, Marpadga Amarender Reddy
1Department of Diabetes and Endocrinology, Beckman Research Institute of City of Hope, 1500 East Duarte Road, Duarte, CA 91010, USA. rnatarajan@coh.org
Current Opinion in Pharmacology
|April 12, 2003
Summary
Arachidonic acid metabolites, including hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids, are crucial in kidney disease pathogenesis. These eicosanoids impact vascular homeostasis, inflammation, and cell growth, offering new therapeutic targets.
Area of Science:
- Nephrology
- Molecular Biology
- Cardiovascular Research
Background:
- Cyclooxygenase and cytochrome P450 metabolites of arachidonic acid have well-established renal vascular effects.
- Emerging research highlights roles for lipoxygenase and cytochrome P450 pathway metabolites in kidney disease.
Purpose of the Study:
- To explore the novel roles of specific arachidonic acid metabolites in kidney disease pathogenesis.
- To understand how these metabolites influence glomerular cells and disease processes.
Main Methods:
- Investigated the effects of hydroxyeicosatetraenoic acids (HETEs) and epoxyeicosatrienoic acids (EETs).
- Examined the modulation of vascular homeostasis, inflammation, cellular growth, apoptosis, and oxidant stress.
- Analyzed the activation of signal transduction pathways and gene expression.
Main Results:
- Arachidonic acid metabolites from lipoxygenase and cytochrome P450 pathways significantly impact glomerular mesangial and epithelial cells.
- These eicosanoids modulate key pathological processes in diabetes and hypertension-related kidney disease.
- Eicosanoids influence vascular homeostasis, inflammation, cell proliferation, apoptosis, and oxidative stress.
Conclusions:
- Oxidized lipids, specifically eicosanoids, play critical roles in kidney physiology and pathology.
- Activation of signaling pathways and gene expression by these lipids is central to their function.
- These findings offer insights into potential therapeutic strategies for diabetic and hypertensive nephropathy.